Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

AMAZON CEO TAKES AIM AT NVIDIA, INTEL, STARLINK, MORE IN ANNUAL SHAREHOLDER LETTER

Amazon CEO Andy Jassy recently published an annual shareholder letter that takes aim at several competitors, including Microsoft, Intel, Nvidia, Starlink, and OpenAI. Demand for Amazon's newest chip, Trainium 3, is so high that it is nearly sold out. AWS' homegrown CPU, Graviton, is now used expansively by 98% of the top 1,000 EC2 customers. Amazon Leo, scheduled to launch in mid-2026, is already succeeding. AWS plans to spend $200 billion on capex in 2026, mostly on building out data centers.

MOVING FROM WORDPRESS TO JEKYLL (AND STATIC SITE GENERATORS IN GENERAL)

DemandSphere migrated its website from WordPress to the static site generator Jekyll to resolve issues with speed, ease of modification, and general development limitations. This extensive effort was significantly supported by AI-assisted development using Claude Code to build custom tools for comprehensive auditing, resulting in improved performance, a robust SEO architecture, and faster, higher-quality content execution.

PICSART LAUNCHES "EARN WITH PICSART", A MONETISATION PROGRAMME

Earn with Picsart is a monetization program open to all 130+ million users that pays creators based on content performance rather than follower count. Creators browse campaign prompts, create content using Picsart's tools, post to social media platforms, and earn money based on engagement metrics like views and shares. This launch, along with their AI agent marketplace, signals Picsart's transition from a design tool to a full creator economy platform.

HOW NASA BUILT ARTEMIS II'S FAULT-TOLERANT COMPUTER

The changes from Apollo to Artemis represent a massive leap in software complexity. Today's software manages every thermal valve and power relay, making it a challenge to ensure the software remains synchronized and valid while under a barrage of cosmic radiation. This article discusses Orion's zero-tolerance architecture and how it offers a preview of a future where mainstream computing can achieve the same always-on resilience required for space.

CLINICAL TRIAL SHOWS GENE EDITING WORKS FOR Β-THALASSAEMIA, TOO

β-Thalassaemia, a disease closely related to sickle-cell anemia, is caused by a large range of mutations, so it can't be fixed with a single editing system. Researchers took an approach that involved reactivating the fetal version of the gene, which has a higher affinity for oxygen than normal hemoglobin. Editing the gene in patient stem cells and transplanting them back resulted in the patients' hemoglobin levels rising. All patients in the trial saw side effects, but they met the trial's key success metric of going over six months without needing a transfusion to control their disease.

TLDR IndexPage 1